Knoll Capital Management as of June 30, 2017
Portfolio Holdings for Knoll Capital Management
Knoll Capital Management holds 15 positions in its portfolio as reported in the June 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Corbus Pharmaceuticals Hldgs | 31.2 | $24M | 3.7M | 6.30 | |
| Biohaven Pharmaceutical Holding | 26.8 | $20M | 807k | 25.00 | |
| Abeona Therapeutics | 20.0 | $15M | 2.4M | 6.40 | |
| Anavex Life Sciences (AVXL) | 5.1 | $3.9M | 724k | 5.32 | |
| Vascular Biogenics | 5.1 | $3.8M | 861k | 4.45 | |
| Volitionrx (VNRX) | 2.1 | $1.6M | 462k | 3.51 | |
| Keryx Biopharmaceuticals | 1.9 | $1.4M | 200k | 7.23 | |
| Ampio Pharmaceuticals | 1.8 | $1.3M | 2.6M | 0.52 | |
| Alcobra | 1.8 | $1.4M | 1.2M | 1.12 | |
| Summit Therapeutics Plc spons ads | 1.5 | $1.1M | 100k | 10.99 | |
| Aldeyra Therapeutics (ALDX) | 0.8 | $583k | 124k | 4.70 | |
| Caladrius Biosciences Ord | 0.7 | $549k | 118k | 4.65 | |
| Evoke Pharma | 0.6 | $448k | 175k | 2.56 | |
| Advaxis | 0.5 | $368k | 113k | 3.27 | |
| Lipocine | 0.1 | $101k | 25k | 4.04 |
